Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:6.3.4.6 (urease)
 7,490 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A new immunoassay technique based on measurement of conductance changes in solutions is described. The assay employs an immobilized monoclonal antibody to capture a protein analyte along with a second antibody to the same analyte, conjugated to an enzyme capable of producing ions which are measured conductimetrically. Urease was selected as the enzyme, because it produces, from urea, four ions for each catalytic event. The analyte studied was human chorionic gonadotropin in serum. Higher concentrations of analyte during incubation with immobilized antibody and antibody-urease conjugate led to increased binding of the latter. After removal of unbound conjugate, urea solution was added and the rate of conductance change measured in the bulk substrate solution. Experiments, performed in polystyrene microtiter wells using a specially designed electrode, demonstrated the ability to measure 30 picomolar concentrations of human chorionic gonadotropin with a 30-s rate measurement. Urease proved to be an excellent labeling enzyme, retaining its activity under the nonionic conditions necessary to maintain low background conductance. Good agreement was obtained between observed rates and those expected from conductimetric theory and known physical parameters. The potential utility of the conductimetric immunoassay lies in the fabrication of biosensor devices for simplification and cost reduction of immunochemical-based instrumentation. Further improvements to the technique are proposed to achieve lower detection limits.
 ...
PMID:Enzyme-amplified rate conductimetric immunoassay. 186 33

A sensitive sandwich immunoassay for human chorionic gonadotropin (hCG) was developed with biotin-mediated filtration capture and silicon sensor detection. A high density of biotin on the membrane assured efficient capture of complexes containing streptavidin and analyte. Capture efficiency was not affected over a wide range of filtration flow rates or biotin concentrations. The assay utilized the pH sensing ability of the light addressable potentiometric sensor (LAPS) for the detection of urease-antibody conjugates. A LAPS reader was constructed which allowed the enzyme conjugate to be detected in approximately 1 microliter volumes. Effects from variations in detection volume were studied. 10 pg of hCG could be detected in an assay time of 20 min with four standard deviations separation from background. Comparison to a commercial RIA was made.
 ...
PMID:A silicon sensor-based filtration immunoassay using biotin-mediated capture. 223 Jan 51

A quantitative capillary tube enzyme immunoassay (CTEIA) method for the determination of human urinary chorionic gonadotropin (hCG) has been developed. The method utilizes an antibody-coated capillary tube through which the test fluid is passed and a urease-labelled second antibody in an immunometric format. Any hCG in the test solution is 'captured' by the immobilized antibody which is hybridoma derived and specific for the beta-subunit of hCG. The second hCG-specific antibody, conjugated to the enzyme urease, is used to detect the captured hCG on the internal surface of the capillary tube. The amount of urease bound to the surface is determined by the introduction of a substrate solution containing urea and the pH indicator bromothymol blue. The rate of colour change, from yellow to blue, caused by the release of ammonia from urea by urease, is determined in a spectrophotometer using a cell holder adapted to accommodate capillary tubes. The initial rate of absorbance change is directly proportional to the concentration of hCG in the sample in the range 0-100 mIU/ml. The test can detect concentrations of hCG as low as 10 mIU/ml in a total elapsed time of 5 min.
 ...
PMID:A rapid quantitative capillary tube enzyme immunoassay for human chorionic gonadotropin in urine. 243 10